Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 10, 2026
An update on cystic fibrosis Hepato-biliary involvementA Jay Freeman, Frank A J A BodewesPediatric Pulmonology|July 22, 2016
Gastroenterological endpoints in drug trials for cystic fibrosisFrank A J A Bodewes, Henkjan J Verkade, Micheal WilschanskiJournal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2018
Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosisIvo P van de Peppel, Frank A J A Bodewes, Henkjan J Verkade, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 14, 2015
Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulationFrank A J A Bodewes, Henkjan J Verkade, Jan A J M Taminiau, et al.Journal of Pediatric Gastroenterology and Nutrition|February 7, 2015
Increase of Serum γ-Glutamyltransferase Associated With Development of Cirrhotic Cystic Fibrosis Liver DiseaseFrank A J A Bodewes, Hubert P J van der Doef, Roderick H J Houwen, et al.Current Opinion in Pulmonary Medicine|August 25, 2017
Diagnosis, follow-up and treatment of cystic fibrosis-related liver diseaseIvo P van de Peppel, Anna Bertolini, Johan W Jonker, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 17, 2025
Characteristics and outcomes of people with cystic fibrosis on the Eurotransplant liver transplantation waiting listMarissa I van der Spek, Henkjan J Verkade, Johan W Jonker, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|February 4, 2012
Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in miceFrank A J A Bodewes, Marjan Wouthuyzen-Bakker, Marcel J Bijvelds, et al.Journal of Pediatric Gastroenterology and Nutrition|January 31, 2024
Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position PaperFrank A J A Bodewes, Alvin Jay Freeman, Alexander Weymann, et al.Journal of Pediatric Gastroenterology and Nutrition|August 1, 2019
Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel DiseaseSjoukje-Marije Haisma, Henkjan J Verkade, Rene Scheenstra, et al.Pageof 3